Lonza News 18. Mai 2026 Bristol Myers Squibb Bolsters Oncology Pipeline with Lonza Licensing Agreement - CHEManager
Endpoints News 18. Mai 2026 FDA approves AstraZeneca’s baxdrostat for certain patients with hypertension
FierceBiotech 18. Mai 2026 Ipsen unveils data for Botox rival that drove long-acting anti-wrinkle jab into phase 3
MACHEREY-NAGEL GmbH & Co. KG 18. Mai 2026 $1 Billion Human Identification Market Analysis by Product, Technology, Application, End User and Region - Forecast to 2031 - Yahoo Finance
Ningbo HEALTH Gene Technologies Co., Ltd. 18. Mai 2026 $1 Billion Human Identification Market Analysis by Product, Technology, Application, End User and Region - Forecast to 2031 - Yahoo! Finance Canada
FierceBiotech 18. Mai 2026 Analysts ‘shaking heads’ after Regeneron melanoma drug fails to beat Keytruda in phase 3 trial
BioPharma Dive 18. Mai 2026 Unlocking more value from mature drug products through strategic outsourcing
Novo Nordisk 18. Mai 2026 Meta founder’s biotech bets on AI to cut costs for Parkinson’s cell therapy - Новости GxP
Merck & Co. 18. Mai 2026 Microbiotica Announces Positive Results from its Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma - The Manila Times
Charles River 18. Mai 2026 Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers - StockStory
Mettler Toledo 18. Mai 2026 Mettler-Toledo stock (US5926881054): solid Q1 2026 growth keeps focus on margin and automation - AD HOC NEWS
Mettler Toledo 18. Mai 2026 How Investors Are Reacting To Mettler-Toledo International (MTD) Q1 Beat And 2026 Sales Growth Outlook - simplywall.st
Bio-Rad 18. Mai 2026 How Investors Are Reacting To Bio-Rad Laboratories (BIO) As RBC Sees Margin Upside Under New Leadership - simplywall.st
Charles River 18. Mai 2026 Charles River Laboratories stock (US1591881009): Q1 results, guidance and what matters for investors - AD HOC NEWS
GCC 18. Mai 2026 GCC Hydroxypropyl Methylcellulose Market Report 2026–2034 | Construction and Pharma Trends - vocal.media